Frank Stokes

Frank Stokes

DirectoratCastle Biosciences· In proxies 2021–2025

Pay in FY2025+5% from the year before · Castle Biosciences stock +46.0% the same year

Frank Stokes was paid $2.4M in FY2025 (Dec), up 5%. Castle Biosciences stock rose 46.0% that year.

Pay$100 in the stock at the end of FY20 → $58
Pay is from the Summary Compensation Table of each Castle Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ExagenPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Castle BiosciencesPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role -49%
  3. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  4. Directors:Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • ExagenDirector · 4 yr on the boardIndependentAudit (Chair), Nominating—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?